- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 6 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Covalent)
PC1.1: 37 residues within 4Å:- Chain E: L.32, Y.33, S.35, F.36, Y.37, S.39, Q.40, T.43, K.44, Y.45, M.47, V.48, F.49
- Chain G: F.91, F.92, F.105
- Chain L: L.14, V.18
- Chain R: L.66
- Chain S: A.61, Y.62
- Chain W: M.88, L.91, T.95, R.96, A.97, F.98, P.99, F.100
- Chain X: L.215, A.217, Y.218, M.219
- Ligands: CDL.3, PEE.5, PEE.6, CDL.9
16 PLIP interactions:1 interactions with chain L, 2 interactions with chain G, 8 interactions with chain E, 5 interactions with chain W- Hydrophobic interactions: L:L.14, G:F.91, G:F.105, E:Y.33, E:F.36, E:F.36, E:V.48, W:L.91, W:R.96
- Hydrogen bonds: E:S.39, E:Q.40, E:Q.40, E:T.43
- Salt bridges: W:R.96, W:R.96
- pi-Cation interactions: W:F.100
PC1.4: 26 residues within 4Å:- Chain E: P.9, L.10, G.11, V.12, R.15, V.17, G.20, M.21, S.23, F.24, I.25
- Chain H: W.45, F.54, L.57, F.58
- Chain S: M.79, Y.82, L.83, I.86, F.87
- Chain V: Q.242, P.243, S.247
- Ligands: CDL.3, PEE.6, CDL.9
6 PLIP interactions:2 interactions with chain S, 2 interactions with chain E, 2 interactions with chain H- Hydrophobic interactions: S:Y.82, S:F.87, H:F.58, H:F.58
- Hydrogen bonds: E:G.20
- Salt bridges: E:R.15
PC1.14: 26 residues within 4Å:- Chain F: P.167, F.171, F.205, F.206, C.209, Y.210, S.212, Y.213, L.216, T.217
- Chain K: T.178, S.179
- Chain M: W.269, T.274, F.277, F.281
- Chain P: Y.73, Y.76, K.77, H.80
- Chain S: F.271, T.272
- Chain W: P.83, F.85
- Ligands: CDL.13, CDL.20
11 PLIP interactions:3 interactions with chain F, 3 interactions with chain M, 2 interactions with chain S, 2 interactions with chain P, 1 interactions with chain W- Hydrophobic interactions: F:F.205, F:F.206, F:Y.213, S:F.271, S:F.271, W:F.85
- Hydrogen bonds: M:W.269, M:T.274, M:T.274, P:Y.73
- Salt bridges: P:K.77
PC1.22: 36 residues within 4Å:- Chain 2: L.32, Y.33, S.35, F.36, Y.37, S.39, Q.40, T.43, K.44, M.47, V.48, F.49
- Chain 4: F.91, F.92, F.105
- Chain 9: L.14, V.18
- Ligands: CDL.24, PEE.26, PEE.27, CDL.30
- Chain f: L.66
- Chain g: A.61, Y.62
- Chain k: M.88, L.91, T.95, R.96, A.97, F.98, P.99, F.100
- Chain l: L.215, A.217, Y.218, M.219
15 PLIP interactions:5 interactions with chain k, 1 interactions with chain 9, 1 interactions with chain f, 7 interactions with chain 2, 1 interactions with chain 4- Hydrophobic interactions: k:L.91, k:P.99, 9:L.14, f:L.66, 2:L.32, 2:Y.33, 2:V.48, 4:F.105
- Salt bridges: k:R.96, k:R.96
- pi-Cation interactions: k:F.100
- Hydrogen bonds: 2:S.39, 2:Q.40, 2:Q.40, 2:T.43
PC1.25: 25 residues within 4Å:- Chain 2: P.9, L.10, G.11, V.12, R.15, V.17, G.20, M.21, S.23, I.25
- Chain 5: W.45, F.54, L.57, F.58
- Ligands: CDL.24, PEE.27, CDL.30
- Chain g: M.79, Y.82, L.83, I.86, F.87
- Chain j: Q.242, P.243, S.247
9 PLIP interactions:3 interactions with chain g, 3 interactions with chain 5, 3 interactions with chain 2- Hydrophobic interactions: g:Y.82, g:I.86, g:F.87, 5:F.58, 5:F.58, 5:F.58
- Hydrogen bonds: 2:G.20, 2:M.21
- Salt bridges: 2:R.15
PC1.37: 26 residues within 4Å:- Chain 3: P.167, F.171, F.205, F.206, C.209, Y.210, S.212, Y.213, L.216, T.217
- Chain 8: T.178, S.179
- Ligands: CDL.36, CDL.43
- Chain a: W.269, T.274, F.277, F.281
- Chain d: Y.73, Y.76, K.77, H.80
- Chain g: F.271, T.272
- Chain k: P.83, F.85
9 PLIP interactions:1 interactions with chain g, 2 interactions with chain d, 1 interactions with chain k, 2 interactions with chain 3, 3 interactions with chain a- Hydrophobic interactions: g:F.271, k:F.85, 3:F.206, 3:Y.213
- Hydrogen bonds: d:Y.73, a:W.269, a:T.274, a:T.274
- Salt bridges: d:K.77
- 14 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
LMT.2: 13 residues within 4Å:- Chain E: F.56, F.60, T.64, K.65, D.99, D.100, E.101
- Chain L: A.26, A.29, W.30, N.34, R.55
- Ligands: CDL.9
8 PLIP interactions:6 interactions with chain E, 2 interactions with chain L- Hydrophobic interactions: E:F.60, L:A.26
- Hydrogen bonds: E:D.99, E:D.99, E:D.100, E:D.100, E:E.101, L:R.55
LMT.8: 19 residues within 4Å:- Chain H: F.62, Q.65, G.66, T.69
- Chain I: G.56, L.59, Y.60, M.63, R.64, F.68, T.70, E.71
- Chain J: R.222, R.223, A.224, R.225
- Ligands: CDL.7, LMT.11, LMT.17
7 PLIP interactions:1 interactions with chain H, 2 interactions with chain I, 4 interactions with chain J- Hydrogen bonds: H:Q.65, I:E.71, J:R.222, J:R.223, J:R.225
- Hydrophobic interactions: I:Y.60
- Salt bridges: J:R.222
LMT.11: 15 residues within 4Å:- Chain H: Y.64, Q.65, K.68
- Chain J: R.222, R.223
- Chain L: N.28, A.29, R.31, E.32, L.33, G.35, P.52, S.53
- Ligands: LMT.8, CDL.9
10 PLIP interactions:3 interactions with chain L, 4 interactions with chain J, 3 interactions with chain H- Hydrophobic interactions: L:N.28, L:E.32
- Hydrogen bonds: L:N.28, J:R.222, J:R.222, J:R.223, J:R.223, H:Q.65, H:K.68
- Salt bridges: H:K.68
LMT.15: 18 residues within 4Å:- Chain G: P.114, P.115, P.116, K.117, L.120
- Chain J: R.225
- Chain R: F.140, V.141, F.145, Y.146, Q.147, R.148, R.149, P.150
- Chain W: S.60, T.62
- Ligands: CDL.7, LMT.17
6 PLIP interactions:4 interactions with chain R, 2 interactions with chain G- Hydrophobic interactions: R:Y.146, R:Y.146
- Hydrogen bonds: R:F.145, R:R.148, G:P.115, G:K.117
LMT.17: 18 residues within 4Å:- Chain H: L.55, F.58, T.59, P.61, F.62, Q.65
- Chain J: R.225
- Chain R: Y.146
- Chain S: F.87, C.90, A.91, I.94
- Ligands: PEE.6, CDL.7, LMT.8, CDL.9, LMT.15, CDL.18
4 PLIP interactions:2 interactions with chain H, 1 interactions with chain J, 1 interactions with chain R- Hydrophobic interactions: H:L.55
- Hydrogen bonds: H:F.58, R:Y.146
- Salt bridges: J:R.225
LMT.19: 14 residues within 4Å:- Chain 4: G.205
- Chain F: V.165, L.168, L.169, S.172, V.173, E.176
- Chain S: L.269, N.274, L.276, S.277, G.278, N.291
- Ligands: CDL.20
6 PLIP interactions:3 interactions with chain F, 3 interactions with chain S- Hydrophobic interactions: F:L.168, F:L.169, S:L.269
- Hydrogen bonds: F:E.176, S:L.276, S:N.291
LMT.21: 14 residues within 4Å:- Chain F: T.161, A.164
- Chain G: R.122
- Chain L: F.9
- Chain S: D.259, H.260, Y.264
- Chain T: M.117, N.120, A.121, Y.124, C.125
- Ligands: PEE.5, CDL.20
5 PLIP interactions:1 interactions with chain T, 2 interactions with chain S, 1 interactions with chain F, 1 interactions with chain G- Hydrophobic interactions: T:A.121, F:T.161
- Hydrogen bonds: S:D.259, S:Y.264, G:R.122
LMT.23: 14 residues within 4Å:- Chain 2: F.56, F.60, T.64, K.65, D.99, D.100, E.101
- Chain 9: A.26, A.29, W.30, L.33, N.34, R.55
- Ligands: CDL.30
8 PLIP interactions:6 interactions with chain 2, 2 interactions with chain 9- Hydrophobic interactions: 2:F.60, 9:A.26
- Hydrogen bonds: 2:D.99, 2:D.99, 2:D.100, 2:D.100, 2:E.101, 9:R.55
LMT.29: 19 residues within 4Å:- Chain 5: Q.65, G.66, T.69
- Chain 6: G.56, L.59, Y.60, M.63, R.64, F.68, T.70, E.71
- Chain 7: D.221, R.222, R.223, A.224, R.225
- Ligands: CDL.28, LMT.32, LMT.40
6 PLIP interactions:1 interactions with chain 6, 4 interactions with chain 7, 1 interactions with chain 5- Hydrogen bonds: 6:E.71, 7:R.222, 7:R.222, 7:R.225, 5:Q.65
- Salt bridges: 7:R.222
LMT.32: 15 residues within 4Å:- Chain 5: Y.64, Q.65, K.68
- Chain 7: R.222, R.223
- Chain 9: N.28, A.29, R.31, E.32, L.33, G.35, P.52, S.53
- Ligands: LMT.29, CDL.30
9 PLIP interactions:4 interactions with chain 7, 3 interactions with chain 5, 2 interactions with chain 9- Hydrogen bonds: 7:R.222, 7:R.222, 7:R.223, 7:R.223, 5:Q.65, 5:K.68, 9:N.28
- Salt bridges: 5:K.68
- Hydrophobic interactions: 9:N.28
LMT.38: 18 residues within 4Å:- Chain 4: P.114, P.115, P.116, K.117, L.120
- Chain 7: R.225
- Ligands: CDL.28, LMT.40
- Chain f: F.140, V.141, F.145, Y.146, Q.147, R.148, R.149, P.150
- Chain k: S.60, T.62
6 PLIP interactions:4 interactions with chain f, 2 interactions with chain 4- Hydrophobic interactions: f:Y.146, f:Y.146
- Hydrogen bonds: f:F.145, f:R.148, 4:P.115, 4:K.117
LMT.40: 18 residues within 4Å:- Chain 5: L.55, F.58, T.59, P.61, F.62, Q.65
- Chain 7: R.225
- Ligands: PEE.27, CDL.28, LMT.29, CDL.30, LMT.38, CDL.41
- Chain f: Y.146
- Chain g: F.87, C.90, A.91, I.94
4 PLIP interactions:1 interactions with chain f, 1 interactions with chain 7, 2 interactions with chain 5- Hydrogen bonds: f:Y.146, 5:F.58
- Salt bridges: 7:R.225
- Hydrophobic interactions: 5:F.58
LMT.42: 14 residues within 4Å:- Chain 3: V.165, L.168, L.169, S.172, V.173, E.176
- Chain G: G.205
- Ligands: CDL.43
- Chain g: L.269, N.274, L.276, S.277, G.278, N.291
5 PLIP interactions:2 interactions with chain g, 3 interactions with chain 3- Hydrophobic interactions: g:L.269, 3:L.168, 3:L.169
- Hydrogen bonds: g:L.276, 3:E.176
LMT.44: 14 residues within 4Å:- Chain 3: T.161, A.164
- Chain 4: R.122
- Chain 9: F.9
- Ligands: PEE.26, CDL.43
- Chain g: D.259, H.260, Y.264
- Chain h: M.117, N.120, A.121, Y.124, C.125
5 PLIP interactions:1 interactions with chain 3, 2 interactions with chain g, 1 interactions with chain h, 1 interactions with chain 4- Hydrophobic interactions: 3:T.161, h:A.121
- Hydrogen bonds: g:D.259, g:Y.264, 4:R.122
- 18 x CDL: CARDIOLIPIN(Non-covalent)
CDL.3: 35 residues within 4Å:- Chain E: M.21, F.24, R.28, R.31, L.32, S.35, V.48, P.52
- Chain G: F.89, F.90, F.91, F.92, F.104
- Chain L: P.22, W.25, A.26
- Chain R: L.74, P.75
- Chain S: Y.71, F.72, F.75, I.76, M.79, L.83
- Chain V: V.245, Y.248
- Chain W: L.91, T.92, T.95, R.96
- Ligands: PC1.1, PC1.4, PEE.6, CDL.9, CDL.18
Ligand excluded by PLIPCDL.7: 23 residues within 4Å:- Chain H: T.59, F.62, W.63
- Chain I: A.53, G.56, Y.57, Y.60, R.61, R.64
- Chain K: W.196
- Chain R: F.140, Y.144, F.145, R.148
- Chain S: V.101, V.105, F.123, F.126
- Chain W: T.62
- Ligands: LMT.8, LMT.15, PEE.16, LMT.17
Ligand excluded by PLIPCDL.9: 25 residues within 4Å:- Chain E: F.24, R.28
- Chain G: W.108, R.110
- Chain H: F.58, S.60, P.61, Y.64, Q.65
- Chain J: R.225, K.228, I.231
- Chain L: L.21, I.24, W.25, N.28, A.29
- Ligands: PC1.1, LMT.2, CDL.3, PC1.4, PEE.5, PEE.6, LMT.11, LMT.17
Ligand excluded by PLIPCDL.10: 40 residues within 4Å:- Chain 3: S.187, G.188, L.189, F.192
- Chain K: F.186, W.187, S.189, L.190
- Chain M: L.251, C.252, L.254, G.255, V.256, F.258, G.259, L.260
- Chain P: F.5, Y.8, I.9, A.12, I.16, V.36, Y.37, A.40, T.75, A.78, W.79, M.81, I.82, Y.83, R.86, K.90
- Chain U: W.157, E.158, S.159, L.160, R.161
- Ligands: CDL.13, PEE.16, CDL.33
Ligand excluded by PLIPCDL.12: 20 residues within 4Å:- Chain 3: L.189, F.190, F.192, L.193, F.194, F.196, V.197
- Chain M: N.244, L.245, V.246, S.247
- Chain P: I.16, N.17, P.18, V.19, Q.20, W.21, T.22, R.23
- Chain U: L.160
Ligand excluded by PLIPCDL.13: 38 residues within 4Å:- Chain K: R.181, T.182, Y.183, L.184, P.185, F.186
- Chain P: G.2, F.3, F.5, Y.8, A.15, W.43, T.44, Q.47, F.48, I.51, Y.76, W.79, Y.83, M.84, K.87
- Chain T: S.137, M.140, F.141, G.144, L.145, Y.147, L.148
- Chain W: S.66, F.70, L.71, P.72, P.74
- Ligands: CDL.10, PC1.14, PEE.16, CDL.18, CDL.20
Ligand excluded by PLIPCDL.18: 42 residues within 4Å:- Chain G: N.69, P.74, V.75, W.76, F.79, F.90, W.96, A.100, A.101, A.103, F.104, W.107
- Chain R: F.123, Q.126, S.127, V.130, Y.131, V.134, A.135, A.138, S.139, H.142
- Chain S: A.91, I.94, K.95
- Chain T: F.139, M.140, L.143, G.144, A.146, Y.147, M.150
- Chain W: I.68, F.69, F.70, L.71, K.73
- Ligands: CDL.3, PEE.6, CDL.13, LMT.17, CDL.20
Ligand excluded by PLIPCDL.20: 33 residues within 4Å:- Chain K: S.179, R.181
- Chain P: F.48, L.72, Y.73, T.75, Y.76
- Chain S: F.267, L.269, G.270, F.271, T.272, A.273
- Chain T: Y.124, F.129, F.130, Y.134, S.137, I.138, F.141, Y.147, L.148, L.151
- Chain W: L.71, L.78, I.80, L.82
- Ligands: PEE.5, CDL.13, PC1.14, CDL.18, LMT.19, LMT.21
Ligand excluded by PLIPCDL.24: 35 residues within 4Å:- Chain 2: M.21, F.24, R.28, R.31, L.32, S.35, V.48, P.52
- Chain 4: F.89, F.90, F.91, F.92, F.104
- Chain 9: P.22, W.25, A.26
- Ligands: PC1.22, PC1.25, PEE.27, CDL.30, CDL.41
- Chain f: L.74, P.75
- Chain g: Y.71, F.72, F.75, I.76, M.79, L.83
- Chain j: V.245, Y.248
- Chain k: L.91, T.92, T.95, R.96
Ligand excluded by PLIPCDL.28: 23 residues within 4Å:- Chain 5: T.59, F.62, W.63
- Chain 6: A.53, G.56, Y.57, Y.60, R.61, R.64
- Chain 8: W.196
- Ligands: LMT.29, LMT.38, PEE.39, LMT.40
- Chain f: F.140, Y.144, F.145, R.148
- Chain g: V.101, V.105, F.123, F.126
- Chain k: T.62
Ligand excluded by PLIPCDL.30: 25 residues within 4Å:- Chain 2: F.24, R.28
- Chain 4: W.108, R.110
- Chain 5: F.58, S.60, P.61, Y.64, Q.65
- Chain 7: R.225, K.228, I.231
- Chain 9: L.21, I.24, W.25, N.28, A.29
- Ligands: PC1.22, LMT.23, CDL.24, PC1.25, PEE.26, PEE.27, LMT.32, LMT.40
Ligand excluded by PLIPCDL.31: 40 residues within 4Å:- Chain 8: F.186, W.187, S.189, L.190
- Chain F: S.187, G.188, L.189, F.192
- Ligands: CDL.35, CDL.36, PEE.39
- Chain a: L.251, C.252, L.254, G.255, V.256, F.258, G.259, L.260
- Chain d: F.5, Y.8, I.9, A.12, I.16, V.36, Y.37, A.40, T.75, A.78, W.79, M.81, I.82, Y.83, R.86, K.90
- Chain i: W.157, E.158, S.159, L.160, R.161
Ligand excluded by PLIPCDL.33: 42 residues within 4Å:- Chain M: R.101, L.245, S.248, Y.249, C.252, V.256, L.260, L.265
- Chain P: H.4, F.5, Q.6, W.61, W.62, V.71, G.74, T.75, K.77, A.78, M.81
- Ligands: CDL.10, CDL.35
- Chain a: Y.97, K.99, L.265, F.270, T.274, F.275, G.278, A.279, Y.282, M.283
- Chain d: W.61, W.62, Q.63, N.64, P.65, L.70, V.71, Y.73, G.74, K.77, M.81
Ligand excluded by PLIPCDL.34: 20 residues within 4Å:- Chain F: L.189, F.190, F.192, L.193, F.194, F.196, V.197
- Chain a: N.244, L.245, V.246, S.247
- Chain d: I.16, N.17, P.18, V.19, Q.20, W.21, T.22, R.23
- Chain i: L.160
Ligand excluded by PLIPCDL.35: 43 residues within 4Å:- Chain M: Y.97, K.99, L.265, F.270, T.274, F.275, G.278, A.279, Y.282, M.283
- Chain P: W.61, W.62, Q.63, N.64, P.65, L.70, V.71, Y.73, G.74, K.77, M.81
- Ligands: CDL.31, CDL.33
- Chain a: R.101, L.245, S.248, Y.249, C.252, V.256, L.260, L.265
- Chain d: H.4, F.5, Q.6, I.9, W.61, W.62, V.71, G.74, T.75, K.77, A.78, M.81
Ligand excluded by PLIPCDL.36: 38 residues within 4Å:- Chain 8: R.181, T.182, Y.183, L.184, P.185, F.186
- Ligands: CDL.31, PC1.37, PEE.39, CDL.41, CDL.43
- Chain d: G.2, F.3, F.5, Y.8, A.15, W.43, T.44, Q.47, F.48, I.51, Y.76, W.79, Y.83, M.84, K.87
- Chain h: S.137, M.140, F.141, G.144, L.145, Y.147, L.148
- Chain k: S.66, F.70, L.71, P.72, P.74
Ligand excluded by PLIPCDL.41: 42 residues within 4Å:- Chain 4: N.69, P.74, V.75, W.76, F.79, F.90, W.96, A.100, A.101, A.103, F.104, W.107
- Ligands: CDL.24, PEE.27, CDL.36, LMT.40, CDL.43
- Chain f: F.123, Q.126, S.127, V.130, Y.131, V.134, A.135, A.138, S.139, H.142
- Chain g: A.91, I.94, K.95
- Chain h: F.139, M.140, L.143, G.144, A.146, Y.147, M.150
- Chain k: I.68, F.69, F.70, L.71, K.73
Ligand excluded by PLIPCDL.43: 33 residues within 4Å:- Chain 8: S.179, R.181
- Ligands: PEE.26, CDL.36, PC1.37, CDL.41, LMT.42, LMT.44
- Chain d: F.48, L.72, Y.73, T.75, Y.76
- Chain g: F.267, L.269, G.270, F.271, T.272, A.273
- Chain h: Y.124, F.129, F.130, Y.134, S.137, I.138, F.141, Y.147, L.148, L.151
- Chain k: L.71, L.78, I.80, L.82
Ligand excluded by PLIP- 6 x PEE: 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
PEE.5: 37 residues within 4Å:- Chain F: T.160, A.164, L.216, F.220
- Chain G: F.102, F.105, I.106, W.108, S.109, R.110, V.111, F.112
- Chain J: R.225, Y.230, I.231
- Chain L: F.9, A.10, T.13, L.14, D.17, V.18, L.21
- Chain T: L.122, F.130, I.138, F.141, A.142, L.145
- Chain W: F.85, V.86, F.87, M.88
- Ligands: PC1.1, PEE.6, CDL.9, CDL.20, LMT.21
16 PLIP interactions:3 interactions with chain F, 6 interactions with chain G, 2 interactions with chain L, 3 interactions with chain W, 1 interactions with chain J, 1 interactions with chain T- Hydrophobic interactions: F:T.160, F:A.164, F:F.220, G:F.102, G:F.105, L:F.9, L:T.13, W:F.85, W:F.87, W:F.87, T:F.141
- Hydrogen bonds: G:W.108, G:S.109, G:R.110, J:R.225
- Salt bridges: G:R.110
PEE.6: 28 residues within 4Å:- Chain G: F.79, W.80, Q.83, F.89, F.90, F.91, F.104, F.105, W.107, W.108, S.109, R.110, D.113
- Chain J: R.225
- Chain L: V.18, L.21, W.25
- Chain R: Y.146
- Chain S: I.76, L.83, F.87
- Ligands: PC1.1, CDL.3, PC1.4, PEE.5, CDL.9, LMT.17, CDL.18
16 PLIP interactions:12 interactions with chain G, 1 interactions with chain L, 1 interactions with chain J, 2 interactions with chain S- Hydrophobic interactions: G:W.80, G:Q.83, G:F.89, G:F.104, G:F.104, G:F.104, G:F.105, G:F.105, G:W.108, G:W.108, L:W.25, S:F.87, S:F.87
- Hydrogen bonds: G:W.108, G:D.113
- Salt bridges: J:R.225
PEE.16: 22 residues within 4Å:- Chain I: Y.54, Y.57
- Chain K: F.186, W.187, L.190, F.194, W.196
- Chain R: F.140, Y.144, R.148
- Chain S: F.120, F.123, A.124, F.126, I.127, A.128, H.130, M.131
- Chain W: I.68
- Ligands: CDL.7, CDL.10, CDL.13
5 PLIP interactions:1 interactions with chain R, 2 interactions with chain S, 2 interactions with chain K- Salt bridges: R:R.148, S:H.130
- Hydrophobic interactions: S:F.123, K:F.186, K:W.187
PEE.26: 38 residues within 4Å:- Chain 3: T.160, A.164, L.216, F.220
- Chain 4: F.102, F.105, I.106, W.108, S.109, R.110, V.111, F.112
- Chain 7: R.225, Y.230, I.231
- Chain 9: L.7, F.9, A.10, T.13, L.14, D.17, V.18, L.21
- Ligands: PC1.22, PEE.27, CDL.30, CDL.43, LMT.44
- Chain h: L.122, F.130, I.138, F.141, A.142, L.145
- Chain k: F.85, V.86, F.87, M.88
17 PLIP interactions:3 interactions with chain k, 2 interactions with chain h, 3 interactions with chain 3, 6 interactions with chain 4, 2 interactions with chain 9, 1 interactions with chain 7- Hydrophobic interactions: k:F.85, k:F.87, k:F.87, h:F.141, h:L.145, 3:T.160, 3:A.164, 3:F.220, 4:F.102, 4:F.105, 9:F.9, 9:T.13
- Hydrogen bonds: 4:W.108, 4:S.109, 4:R.110, 7:R.225
- Salt bridges: 4:R.110
PEE.27: 28 residues within 4Å:- Chain 4: F.79, W.80, Q.83, F.89, F.90, F.91, F.104, F.105, W.107, W.108, S.109, R.110, D.113
- Chain 7: R.225
- Chain 9: V.18, L.21, W.25
- Ligands: PC1.22, CDL.24, PC1.25, PEE.26, CDL.30, LMT.40, CDL.41
- Chain f: Y.146
- Chain g: I.76, L.83, F.87
13 PLIP interactions:9 interactions with chain 4, 1 interactions with chain 7, 2 interactions with chain g, 1 interactions with chain 9- Hydrophobic interactions:
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 6 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Covalent)
- 14 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 18 x CDL: CARDIOLIPIN(Non-covalent)
- 6 x PEE: 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)